| Basics |
|
Revelation Biosciences, Inc.
|
| IPO Date: |
November 18, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$6.13M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 5.47%
|
| Avg Daily Range (30 D): |
$0.04 | 3.52%
|
| Avg Daily Range (90 D): |
$0.05 | 3.15%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.98M |
| Avg Daily Volume (30 D): |
.08M |
| Avg Daily Volume (90 D): |
.22M |
| Trade Size |
| Avg Trade Size (Sh.): |
267 |
| Avg Trade Size (Sh.) (30 D): |
227 |
| Avg Trade Size (Sh.) (90 D): |
146 |
| Institutional Trades |
| Total Inst.Trades: |
3 |
| Avg Inst. Trade: |
$.84M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-1.77
|
$-7.01
|
$-2.11
|
|
Diluted EPS
|
$-1.77
|
$-7.01
|
$-2.11
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -1.91M
|
$ -2.44M
|
$ -2.05M
|
|
Operating Income / Loss
|
$ -1.94M
|
$ -2.46M
|
$ -2.09M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ M
|
$ 2.79M
|
$ -2.79M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 07, 2025:
1:3
|
|
Jan 28, 2025:
1:16
|
|
Jan 25, 2024:
1:30
|
|
Feb 01, 2023:
1:35
|
|
|
|